3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Carcinoma, Non-Small-Cell Lung
149
Squamous Cell Carcinoma of Head and Neck
76
Head and Neck Neoplasms
75
Stomach Neoplasms
52
Lung Neoplasms
52
Esophageal Neoplasms
34
Neoplasms
33
Uterine Cervical Neoplasms
32
Urinary Bladder Neoplasms
32
Carcinoma, Squamous Cell
27
Parkinson Disease 4, Autosomal Dominant Lewy Body
26
Neoplasm Metastasis
26
Small Cell Lung Carcinoma
23
Breast Neoplasms
23
Cholangiocarcinoma
21
Carcinoma
19
Ovarian Neoplasms
14
Adenocarcinoma Of Esophagus
14
Triple Negative Breast Neoplasms
13
Pancreatic Neoplasms
13
Oropharyngeal Neoplasms
13
Mesothelioma, Malignant
13
Adenocarcinoma
13
Biliary Tract Neoplasms
12
Mesothelioma
11
Gallbladder Neoplasms
11
Esophageal Squamous Cell Carcinoma
10
Carcinoma, Transitional Cell
10
Tongue Neoplasms
9
Laryngeal Neoplasms
9
Interventions
amatuximab
1
Pemetrexed
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Severe combined immunodeficiency with sensitivity to ionizing radiation
×
Cisplatin
×
Clear all
NCT02357147
2020-03-17
ARTEMIS
Morphotek
Phase 2
Terminated
124 enrolled
10 charts